抗淋巴细胞生成,以促进瘤中药物积累
Chunling Wang1,2,3, Junchao Xu1,4, Xiaoyu Cheng2,5
1CAS Key Laboratory for Biomedical Effects of Nanomaterials & Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing, 100190, China.
Signal transduction and targeted therapy
|April 14, 2024
概括
用抗血管性药物向瘤淋巴血管可以提高抗癌药物的积累和有效性. 这种新的策略可以改善治疗结果,同时减少瘤转移,增强抗瘤免疫力.
科学领域:
- 在瘤学瘤学.
- 纳米医学是一种纳米医学.
- 药物运输 药物运输 药物运输
背景情况:
- 不充分的内药物积累限制了治疗疗效.
- 目前改善药物输送的策略往往有助于促进瘤转移的风险.
- 与瘤相关的淋巴血管 (LVs) 是药物积累的一个被低估的因素.
研究的目的:
- 调查向淋巴血管在增强抗癌药物输送中的作用.
- 评估新的抗淋巴细胞生成策略,以改善治疗结果.
- 评估与现有的癌症疗法结合抗淋巴细胞生成药物的潜力.
主要方法:
- 在小鼠癌症模型中使用anlotinib和SAR131675,是淋巴血管生成的抑制剂.
- 评估了这些抑制剂对瘤淋巴血管密度和药物积累的影响.
- 与多克索鲁比辛,脂质体多克索鲁比辛和抗PD-L1抗体结合使用anlotinib,以评估抗瘤有效性和转移.
主要成果:
- 安洛丁尼布和SAR131675显著降低了瘤淋巴血管密度,增强了药物积累.
- 与单一治疗相比,组合疗法显示出更好的抗瘤疗效.
- 该策略有效地减少了瘤转移,并增强了抗瘤免疫反应.
结论:
- 向瘤淋巴血管是一种可行的策略,可以增加瘤内药物积累.
- 将抗淋巴细胞生成剂与治疗药物结合起来,为改善癌症治疗提供了一种有前途的方法.
- 这种在临床上可转移的方法可以提高疗效,而不会增加转移风险.
更多相关视频
09:03Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells
Published on: November 23, 2014
9.8K
10:26Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles
Published on: November 1, 2017
8.5K
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
01:27Tumor Immunotherapy
522
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
522